Dosage and administration
5 drops 2 or 3 times per day, on an empty stomach, 5 days per week or until symptoms abate. Consult a physician for use in children under 12 years of age.
5 drops 2 or 3 times per day, on an empty stomach, 5 days per week or until symptoms abate. Consult a physician for use in children under 12 years of age.
Cochlearia Armoracia 3X, Varicella Zoster Nosode 6X, 8X, 12X, 30X, 200X, 2LM, Spleen (Suis) 8X, Thymus (Suis) 8X, Hepar Suis 8X, Epstein-Barr Virus Nosode 9X, Morbillinum 12X, 30X, 30C, Meningococcus Nosode 15X, 30X, 200X, Parotidinum 15X, 30X, 200X, Rubella Nosode 30X, Poliomyelitis Nosode 30C.
For temporary relief of skin rash, childhood illness, headache, weight loss, mental and physical fatigue, fever, cough, flu-like symptoms, heart palpitations, virus, pain, swelling, stiffness of limbs.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if tamper evident seal is broken or missing.
Store in a cool, dry place.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
5 drops 2 or 3 times per day, on an empty stomach, 5 days per week or until symptoms abate. Consult a physician for use in children under 12 years of age.
For temporary relief of skin rash, childhood illness, headache, weight loss, mental and physical fatigue, fever, cough, flu-like symptoms, heart palpitations, virus, pain, swelling, stiffness of limbs.
Demineralized Water, 25% Ethanol
MFD FOR:
The Wellness Center for
Research and Education, Inc.
1237 S. Victoria Ave. Suite 169
Oxnard CA 93035
1-866-962-6484
Dr. Theresa Dale's
NDC 50181-0042-1
Homeopathic
BioTox
V-MMR
1 fl oz (30 ml)
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50181-0042-1 | 2025-05-28 | C162847 | 48780-1 | 9d75b9d0-45a3-f424-e053-dadaa90a57ce | Drug Facts: |
| 50181-0042-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-45a3-f424-e053-dadaa90a57ce | Drug Facts: |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| HORSERADISH | ACTIVE INGREDIENT | 8DS6G120HJ | 1 | |
| HUMAN HERPESVIRUS 3 | ACTIVE INGREDIENT | 9885M7D6JP | 1 | |
| HUMAN HERPESVIRUS 4 | ACTIVE INGREDIENT | 2A26YW7PNX | 1 | |
| JAPANESE ENCEPHALITIS VIRUS | ACTIVE INGREDIENT | P07E7XWU9D | 1 | |
| MEASLES VIRUS | ACTIVE INGREDIENT | HT3R7C012Q | 1 | |
| MUMPS VIRUS | ACTIVE INGREDIENT | YF0S03R447 | 1 | |
| POLIOVIRUS | ACTIVE INGREDIENT | FZJ641678T | 1 | |
| PORK LIVER | ACTIVE INGREDIENT | 6EC706HI7F | 1 | |
| RUBELLA VIRUS | ACTIVE INGREDIENT | U751HEX436 | 1 | |
| SUS SCROFA SPLEEN | ACTIVE INGREDIENT | 92AMN5J79Y | 1 | |
| SUS SCROFA THYMUS | ACTIVE INGREDIENT | 7B69B0BD62 | 1 | |
| HORSERADISH | ACTIVE MOIETY | 8DS6G120HJ | 1 | |
| HUMAN HERPESVIRUS 3 | ACTIVE MOIETY | 9885M7D6JP | 1 | |
| HUMAN HERPESVIRUS 4 | ACTIVE MOIETY | 2A26YW7PNX | 1 | |
| JAPANESE ENCEPHALITIS VIRUS | ACTIVE MOIETY | P07E7XWU9D | 1 | |
| MEASLES VIRUS | ACTIVE MOIETY | HT3R7C012Q | 1 | |
| MUMPS VIRUS | ACTIVE MOIETY | YF0S03R447 | 1 | |
| POLIOVIRUS | ACTIVE MOIETY | FZJ641678T | 1 | |
| PORK LIVER | ACTIVE MOIETY | 6EC706HI7F | 1 | |
| RUBELLA VIRUS | ACTIVE MOIETY | U751HEX436 | 1 | |
| SUS SCROFA SPLEEN | ACTIVE MOIETY | 92AMN5J79Y | 1 | |
| SUS SCROFA THYMUS | ACTIVE MOIETY | 7B69B0BD62 | 1 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50181-0042 | 50181-0042-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| HORSERADISH | 8DS6G120HJ | ACTIB |
| HUMAN HERPESVIRUS 3 | 9885M7D6JP | ACTIB |
| SUS SCROFA SPLEEN | 92AMN5J79Y | ACTIB |
| SUS SCROFA THYMUS | 7B69B0BD62 | ACTIB |
| PORK LIVER | 6EC706HI7F | ACTIB |
| HUMAN HERPESVIRUS 4 | 2A26YW7PNX | ACTIB |
| MEASLES VIRUS | HT3R7C012Q | ACTIB |
| JAPANESE ENCEPHALITIS VIRUS | P07E7XWU9D | ACTIB |
| MUMPS VIRUS | YF0S03R447 | ACTIB |
| RUBELLA VIRUS | U751HEX436 | ACTIB |
| POLIOVIRUS | FZJ641678T | ACTIB |
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f525b90e-6ebc-4e46-b1c8-be000b54454d | 09a3f8c9-0b00-4739-a04f-4ade3ce97761 | 2025-05-28 | Warnings | f525b90e-6ebc-4e46-b1c8-be000b54454d 09a3f8c9-0b00-4739-a04f-4ade3ce97761 |
Adverse event summaries are temporarily unavailable. Other product information remains available.